At an inflexion point

Company
14 Oct 2024
5 Min read 
  • Tushar Manudhane upgrades IPCA Laboratories to Buy with a target price of INR 1,950.
  •  IPCA's stock info: market cap of INR 419.8 billion, 52-week range of INR 933 to 1659.
  •  Financial snapshot for FY25E: sales of INR 88.9 billion, EBITDA of INR 17.2 billion, adjusted PAT of INR 8.5 billion.
  •  IPCA expected to sustain industry-beating growth in domestic formulation market and generics exports.
  •  Efforts to revive US business, improve MR productivity, and market share gain.
  •  Export formulation business expected to grow at a CAGR of 28% over FY24-27.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority